Home » Topics » Regulatory

Regulatory
RSS

Manufacturing approval obtained for Onoact

July 31, 2002

E.U. approval for cancer imaging agent Flucis

July 30, 2002

ADVENT trial results support expanded indications for Niaspan

July 30, 2002

New formulation of Rapamune introduced in U.K.

July 26, 2002

Eligard 22.5 mg approved for advanced prostate cancer

July 25, 2002

Serono to develop anastrozole for female infertility

July 25, 2002

Nasonex indication expanded to include children as young as two years

July 23, 2002

Aranesp approved for chemotherapy-induced anemia

July 23, 2002

Xyrem approved for cataplexy associated with narcolepsy

July 22, 2002

Busulfex to undergo clinical evaluation in Japan in hematopoietic stem cell transplantation

July 19, 2002

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...